Corcept Therapeutics Inc. (CORT) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "CORT"
      ],
      "issuer_cik": "0001088856",
      "owner_cik": "0001236387",
      "accession_number": "0001193125-26-424350",
      "form_type": "4",
      "filing_date": "2026-10-16",
      "period_of_report": "2026-10-15",
      "issuer_name": "CORCEPT THERAPEUTICS INC",
      "issuer_trading_symbol": "CORT",
      "owner_name": "WILSON JAMES N",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-15",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 6654,
      "transaction_price_per_share": 114.4751,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 1057889,
      "transaction_value": 761717.3154,
      "direct_or_indirect": "I",
      "nature_of_ownership": "James N. Wilson and Pamela D. Wilson Trust",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction."
        },
        {
          "id": "F2",
          "description": "Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.13 to $115.12 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."
        },
        {
          "id": "F5",
          "description": "Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."
        }
      ],
      "remarks": "The power of attorney under which this form was signed is on file with the Commission."
    },
    {
      "tickers": [
        "CORT"
      ],
      "issuer_cik": "0001088856",
      "owner_cik": "0001236387",
      "accession_number": "0001193125-26-424350",
      "form_type": "4",
      "filing_date": "2026-10-16",
      "period_of_report": "2026-10-15",
      "issuer_name": "CORCEPT THERAPEUTICS INC",
      "issuer_trading_symbol": "CORT",
      "owner_name": "WILSON JAMES N",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-15",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 300,
      "transaction_price_per_share": 116.2967,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 1054543,
      "transaction_value": 34889.01,
      "direct_or_indirect": "I",
      "nature_of_ownership": "James N. Wilson and Pamela D. Wilson Trust",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction."
        },
        {
          "id": "F4",
          "description": "Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.19 to $116.35 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."
        },
        {
          "id": "F5",
          "description": "Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."
        }
      ],
      "remarks": "The power of attorney under which this form was signed is on file with the Commission."
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.